Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

Presentation

Rethinking Skin Inflammation Through Shared Immune Programs and Anatomic Skin Niches

Description

In this award lecture on rethinking skin inflammation, the speaker describes research showing that many inflammatory skin diseases are not isolated entities but share common immune programs and molecular pathways. Using large-scale gene expression profiling across more than 35 diseases and hundreds of RNA-seq datasets, the work reveals patterns such as psoriasis clustering distinctly, while other conditions like atopic dermatitis, hidradenitis suppurativa, acne, fibrotic diseases, and scalp disorders show overlap based on shared signals including TNF, IL-17, TH2/IL-13, interferon, antigen presentation, neutrophils, and barrier stress. The lecture also emphasizes that disease expression is strongly shaped by anatomic skin niches: facial skin, flexures, acral sites, scalp, and exposed skin each have different immune environments influenced by hair follicles, sweat, microbiome, friction, UV exposure, blood flow, and tissue architecture. Single-cell and spatial sequencing further show site-specific immune specialization and help explain why the same pathway can manifest differently depending on location. The overall message is that understanding how immune pathways interact with local tissue niches can move dermatology from describing disease patterns to explaining them mechanistically and guide more precise, mechanism-based treatment.

View more

Conclusions

Inflammatory skin diseases are not isolated entities but share many overlapping molecular and cytokine programs across diagnostic categories.
Psoriasis, atopic dermatitis, hidradenitis suppurativa, autoimmune/connective tissue diseases, and fibrotic disorders cluster into recognizable molecular groups based on transcriptomic patterns.
Key inflammatory axes such as TNF/IL-17, interferon, IL-13/TH2, neutrophil, and antigen-presentation pathways recur across multiple skin diseases.
The same immune pathway can manifest as different clinical diseases depending on the anatomic skin niche where it is activated.
Body-site biology strongly shapes disease phenotype, with facial, flexural, acral, scalp, and exposed skin each supporting distinct immune environments.
Single-cell and spatial transcriptomics reveal that local skin architecture and cell composition differ substantially across anatomic sites.
Facial skin shows heightened adaptive immune activity and is associated with diseases like rosacea and lupus.
Flexural skin appears to be an immune cell-rich regulatory niche and is linked to hidradenitis suppurativa and inverse psoriasis.
Acral skin is comparatively immune-dampened and mechanically specialized, helping explain why it is often spared in inflammatory disease but can develop distinct, treatment-resistant disorders.
Scalp skin exhibits stress- and hair-follicle-associated inflammatory programs that predispose it to conditions such as psoriasis and folliculitis.
Site-specific expression of therapeutic targets, such as PDE4, may help explain why certain body regions respond better to particular treatments.
Overall, the study argues that skin inflammation should be understood through the interaction of shared immune pathways with site-specific tissue niches rather than as purely disease-specific entities.
This framework supports a move from descriptive dermatology toward mechanism-based dermatology and more targeted treatment strategies.

Lowell A. Goldsmith, JID 2003
Johann E. Gudjonsson, MD, PhD, FAAD